Spironolactone Tablet, Film Coated
Product Images NDC 68382-660
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 68382-660). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (B9a028ee 5720 4b9e A625 F7130aafd084 02)
This is a statistical analysis comparing the effectiveness of Spironolactone versus Placebo in 822 and 841 individuals respectively. The analysis shows that Spironolactone had a significantly better outcome based on a p-value of less than 0.001. The timeline of the study was measured in months, from 0 to 42.*
Image (B9a028ee 5720 4b9e A625 F7130aafd084 03)
This appears to be a chart of various subgroups, including age, sex, race, heart function, diabetes status, and medication use, among others, for a study or trial related to heart failure. The chart includes the number of participants in each subgroup as well as findings related to different medications and their effectiveness.*
Image4 (B9a028ee 5720 4b9e A625 F7130aafd084 04)
NDC 68382-660-01 - Spironolactone Tablets, USP is a prescription-only drug. Each film-coated tablet contains 25mg of spironolactone, USP. The package insert should be reviewed for complete prescribing information, including usual dosages. The drug should be stored at 20° to 25°C (68° to 77°F), in a light-resistant container, and protected from light. This drug should be kept out of the reach of children. It is manufactured by Cadia Healthcare Ltd. in Baddi, India, and distributed in the United States by Zydus Pharmaceuticals (USA) Inc. based in Pennington, NJ 08534.*
Image5 (B9a028ee 5720 4b9e A625 F7130aafd084 05)
Spironolactone is a USP tablet that comes in a bottle of 100 tablets. Each tablet contains 50mg of spironolactone, which is a diuretic medication. The package insert provides comprehensive prescribing information. The medication should be stored at room temperature, away from light, and in tightly sealed, light-resistant containers. This drug should also be kept out of reach of children. Cadila Healthcare Ltd., Badd, India, manufactures it, and Zydus Pharmaceuticals distributes it from Pennington, NJ 08534.*
Image6 (B9a028ee 5720 4b9e A625 F7130aafd084 06)
NDC 68382-662-01 is a prescription drug containing Spironolactone in the form of 100 tablets, USP used as a diuretic to treat heart failure and for hypertension treatment. It is advised to store the tablets below 25°C, to protect them from light and to keep them away from children. The manufacturer is Cadia Healthcare Ltd., Baddi, India, and distributed by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. For further information, please refer to the packaged insert for complete prescribing information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.